Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Improving Therapy Outcomes in Relapsed/Refractory
Improving Therapy Outcomes in Relapsed/Refractory
by celsa-spraggs
Hodgkin Lymphoma. Program Objectives. Brentuximab...
What Is the Role of
What Is the Role of
by mitsue-stanley
Dual LAMA/LABA Bronchodilation in COPD Therapy in...
Early and Intensive T2D Management:
Early and Intensive T2D Management:
by ellena-manuel
Program Goals. TECOS. Sitagliptin in Patients Wit...
Therapeutic Strategies
Therapeutic Strategies
by liane-varnes
in the Management of Mild-to-Moderate Atopic Derm...
Talking to Patients About Overactive Bladder:
Talking to Patients About Overactive Bladder:
by conchita-marotz
. What Every Provider Should Know. Program Goals...
Patient-Centered Management
Patient-Centered Management
by giovanna-bartolotta
in Metastatic Castration-Resistant Prostate Cance...
Unmet Needs in the Secondary Prevention in ACS
Unmet Needs in the Secondary Prevention in ACS
by marina-yarberry
GRACE. . 5-Year Mortality . Antiplatelet Therap...
Achieving HbA
Achieving HbA
by celsa-spraggs
1c. Goals: Applying Guidelines to Intensify Ther...
ESSENTIAL CONCEPTS IN THE USE OF SOMATOSTATIN ANALOGUES IN PATIENTS WITH NEUROENDOCRINE TUMORS
ESSENTIAL CONCEPTS IN THE USE OF SOMATOSTATIN ANALOGUES IN PATIENTS WITH NEUROENDOCRINE TUMORS
by alida-meadow
Program Goals. Program Outline. History of Carcin...
To Titrate or Not: Optimizing Treatment With Antiepileptic Drugs
To Titrate or Not: Optimizing Treatment With Antiepileptic Drugs
by celsa-spraggs
Program Goals. Epilepsy. Prevalence in the United...
Oral Antiplatelet Therapy in ACS
Oral Antiplatelet Therapy in ACS
by kittie-lecroy
Oral Antiplatelet Therapy in ACS PLATO Primary E...
Post-autologous Transplant Therapy for Hodgkin Lymphoma
Post-autologous Transplant Therapy for Hodgkin Lymphoma
by sherrill-nordquist
Program Goals. cHL. Overview. cHL. Poor Prognosis...
Updates in Diffuse Large B-Cell Lymphoma
Updates in Diffuse Large B-Cell Lymphoma
by sherrill-nordquist
Program Goals. DLBCL Subtypes . 2008 WHO Classifi...
Appropriate Use Criteria for the Risk Assessment of Stable Ischemic Heart Disease
Appropriate Use Criteria for the Risk Assessment of Stable Ischemic Heart Disease
by trish-goza
Spectrum of Ischemic Heart Disease. Management of...
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
How Effective Is Fixed-Dose Combination Therapy in T2D and Where Does It Fit?
by giovanna-bartolotta
Program Goals. Complementary Mechanism of Action ...
Bone-Targeted Therapy in the Adjuvant Breast Cancer Setting
Bone-Targeted Therapy in the Adjuvant Breast Cancer Setting
by tatiana-dople
Cancer-Treatment-Induced Bone Loss (CTIBL). Clodr...
Clinical Considerations in
Clinical Considerations in
by faustina-dinatale
Evidence-based Management . of GIST. Program Goal...
Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen De
Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen De
by jacey
Prostate Cancer . US Medical Affairs, Research . a...
Staying Abreast of Best Practices Across the Clinical Conti
Staying Abreast of Best Practices Across the Clinical Conti
by mitsue-stanley
Diagnostic Criteria. Multiple Myeloma Requiring T...